Jennifer B. Damico - Feb 24, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
SVP & Controller
Signature
Susan E. Grant, by power of atty., for Jennifer B. Damico
Stock symbol
PFE
Transactions as of
Feb 24, 2023
Transactions value $
-$393,542
Form type
4
Date filed
3/17/2023, 04:53 PM
Previous filing
Feb 24, 2023
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Tax liability -$15K -360 -2.15% $41.75 16.4K Feb 24, 2023 Direct F1
transaction PFE Common Stock Sale -$397K -9.91K -52.4% $40.02 9K Mar 15, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $18.2K +451 +2.18% $40.28 21.2K Mar 15, 2023 Common Stock 451 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2 Each unit represents one phantom share of common stock.
F3 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.